Cargando…

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group

OBJECTIVE: This study examined the types of discordance occurring in the diagnosis of soft tissue and visceral sarcomas, gastrointestinal stromal tumors (GIST), and desmoid tumors, as well as the economic impact of diagnostic discrepancies. METHODS: We carried out a retrospective, multicenter analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrier, Lionel, Rascle, Pauline, Morelle, Magali, Toulmonde, Maud, Ranchere Vince, Dominique, Le Cesne, Axel, Terrier, Philippe, Neuville, Agnès, Meeus, Pierre, Farsi, Fadila, Ducimetière, Françoise, Blay, Jean-Yves, Ray Coquard, Isabelle, Coindre, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886412/ https://www.ncbi.nlm.nih.gov/pubmed/29621244 http://dx.doi.org/10.1371/journal.pone.0193330

Ejemplares similares

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study
por: Savina, Marion, et al.
Publicado: (2017)

Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research Program
por: Fayet, Yohan, et al.
Publicado: (2018)

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
por: Cassier, P A, et al.
Publicado: (2010)

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)
por: Derbel, Olfa, et al.
Publicado: (2017)

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome
por: Brahmi, Mehdi, et al.
Publicado: (2015)

Pregnancy in Women with Metastatic Sarcomas
por: Yazigi, Alexandre, et al.
Publicado: (2020)

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions
por: Perrier, Lionel, et al.
Publicado: (2012)

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case–control study—study protocol
por: Lacourt, Aude, et al.
Publicado: (2019)

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
por: Lurkin, Antoine, et al.
Publicado: (2010)

Molecular Mechanisms of Kaposi Sarcoma Development
por: Karabajakian, Andy, et al.
Publicado: (2022)

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
por: Ducimetière, Françoise, et al.
Publicado: (2011)

Prognosis and predictive value of KIT exon 11 deletion in GISTs
por: Bachet, J-B, et al.
Publicado: (2009)

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
por: Brahmi, M., et al.
Publicado: (2021)

No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks’ Outcome?
por: Fayet, Yohan, et al.
Publicado: (2022)

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
por: Dantas-Barbosa, Carmela, et al.
Publicado: (2017)

miRNA Profiling: How to Bypass the Current Difficulties in the Diagnosis and Treatment of Sarcomas
por: Gougelet, Angélique, et al.
Publicado: (2011)

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
por: Duffaud, Florence, et al.
Publicado: (2012)

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
por: Dufresne, A., et al.
Publicado: (2020)

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
por: Toulmonde, Maud, et al.
Publicado: (2023)

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)
por: Poveda, Andrés, et al.
Publicado: (2014)

Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group
por: Brahmi, Mehdi, et al.
Publicado: (2022)

Clear Cell Sarcoma (Malignant Melanoma) of Soft Parts: A Clinicopathologic Study of 52 Cases
por: Hocar, O., et al.
Publicado: (2012)

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
por: de Pinieux, Gonzague, et al.
Publicado: (2021)

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
por: Penel, Nicolas, et al.
Publicado: (2023)

2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
por: Frezza, Anna Maria, et al.
Publicado: (2018)

Desmoid is not a sarcoma; reply to Sachdev et al.
por: van der Graaf, Winette T.A., et al.
Publicado: (2023)

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years
por: Basse, Clémence, et al.
Publicado: (2019)

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience
por: Levard, Alice, et al.
Publicado: (2013)

SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
por: Poveda, A., et al.
Publicado: (2016)

Determinants of the access to remote specialised services provided by national sarcoma reference centres
por: Fayet, Yohan, et al.
Publicado: (2021)

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
por: Ray-Coquard, Isabelle, et al.
Publicado: (2017)

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
por: Blay, Jean-Yves, et al.
Publicado: (2013)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
por: Carbonnaux, Mélodie, et al.
Publicado: (2019)

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
por: Blesius, Aurore, et al.
Publicado: (2011)

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management
por: Dômont, J, et al.
Publicado: (2010)

Desmoid Tumors Arising on the Mesenteric Surgical Scar of Abdominal Sarcomas
por: Damiani, Giovanni, et al.
Publicado: (2022)

Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin
por: Laroche, Audrey, et al.
Publicado: (2015)

The off-label use of targeted therapies in sarcomas: the OUTC’S program
por: Eberst, Lauriane, et al.
Publicado: (2014)

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)
por: Patrikidou, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2s3in1sq1pncs9dffd46kpj1ei